Martin Shkreli made headlines after he bought the rights to Daraprim, a life-saving drug used to fight off infections that is vital to people with weakened immune systems—including AIDS patients. After he securing the rights, he proceeded to price-gouge the medication by jacking the price up by over 5,000%, from $13.50 per dose up to $750.
The 32-year-old hedge fund manager and CEO of Turing Pharmaceuticals has defended his actions, and since pushed down the price from the original $750 amount. It is not yet known exactly how much a dose of the drug will now cost.
You’d think that someone getting such negative press would lay low and that the last thing on Shkreli’s mind right now is his love life, but you’d be wrong.
One user of the popular dating app Tinder, named Eve Peyser, came across Shkreli’s profile and decided it was too good of an opportunity not to swip right.
Peyser confronted Shkreli on his controversial financial move, and didn’t let him off easy.
She shared screenshots of their heated exchange to her Twitter page.
Check out what he had to say in the slideshow above.